A Single Center, Randomized, Open Label, Crossover Study With Ticagrelor and Prasugrel to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
Latest Information Update: 16 Jul 2020
Price :
$35 *
At a glance
- Drugs Prasugrel (Primary) ; Ticagrelor (Primary)
- Indications Cardiovascular disorders
- Focus Pharmacodynamics
- 13 Jul 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 18 Jul 2017 Planned End Date changed from 31 Aug 2017 to 31 Oct 2017.
- 18 Jul 2017 Planned primary completion date changed from 31 Jul 2017 to 31 Oct 2017.